Healthcare shares are generally trading flat in pre-market
Among news in this sector, Abbott Labs (
) is down 0.3% this morning as it reports Q4 EPS of $0.58, in line
with the analyst consensus on Capital IQ. Sales were $5.65 bln, shy
of the Street view of $5.71 bln.
In 2014, the company expects an increase in share buybacks to
more than $2 billion.
For FY 2014 earnings, the company expects ongoing EPS of
$2.16-$2.26 per share. The Street is at $2.21 per share.
And, Integrated life science company Meridian Bioscience (
) reported financial results for Q1, that fell in line with
VIVO reported Q1 earnings of $7.4 million, or $0.18 per diluted
share, compared with the prior-year period's $8.47 million or $0.20
per share. Revenues were $44.8 million, down 1% from $45.35 million
in the same quarter last year.
Analysts polled by Capital IQ were expecting EPS of $0.20 on
revenues of $44.79 million.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.